Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis

Epidemiological studies confirm the high risk of ischemic events in multiple sclerosis (MS) that are associated with increased pro-thrombotic activity of blood platelets. The most potent physiological platelet agonist is thrombin, which activates platelets via cleavage of specific protease-activated...

Descripción completa

Detalles Bibliográficos
Autores principales: Dziedzic, Angela, Miller, Elzbieta, Bijak, Michal, Przyslo, Lukasz, Saluk-Bijak, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589910/
https://www.ncbi.nlm.nih.gov/pubmed/33086557
http://dx.doi.org/10.3390/ijms21207722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589910/
https://www.ncbi.nlm.nih.gov/pubmed/33086557
http://dx.doi.org/10.3390/ijms21207722

Ejemplares similares